A new study in Science identified piperacillin for treating Lyme disease. Researchers tested nearly 500 FDA-approved compounds to find effective drugs. Piperacillin, related to penicillin, best eliminated Lyme-causing bacteria, Borrelia burgdorferi.
Doxycycline is currently the main treatment but has significant drawbacks. It harms helpful gut bacteria, causes side effects, and affects children negatively. Doxycycline also leaves 10–20% of Lyme disease cases incompletely treated. Piperacillin provides targeted treatment of Borrelia burgdorferi with fewer side effects.
How Does Piperacillin Treat Lyme Disease?
Researchers found piperacillin disrupts Borrelia‘s unusual cell wall-building process. The antibiotic cured Lyme disease in mice at very low doses. Piperacillin required doses 100 times smaller than doxycycline for effective treatment.
These low doses did not affect the gut microbiome of mice. Smaller doses may help reduce side effects and preserve gut health. Clearing B. burgdorferi completely is important, as leftover cell-wall fragments cause inflammation. Piperacillin could prevent long-term Lyme effects by fully eliminating harmful bacteria.
Dr. Brandon Jutras at Northwestern University led the recent piperacillin research. He hopes this work leads to better tools for Lyme diagnosis and treatment. Symptoms likely depend on genes, immune response, and sensitivity to bacterial remnants.
Dr. Jutras also tested piperacillin with tazobactam. These drugs are often used in tandem. Tazobactam blocks bacterial resistance in strep and other infections. But Lyme bacteria don’t produce beta-lactamase, the bacterial defense that Tazobactam targets.
In fact, adding tazobactam made the treatment broader and less specific. The combination harmed the host’s microbiome more than piperacillin alone. These results confirm piperacillin’s strength as a precise Lyme treatment.
According to Dr. Jutras, this discovery opens the door to customized Lyme care. He says future treatments could match specific Borrelia strains or patient needs.
What Should You Know about Lyme Disease?
Lyme disease is spread by deer ticks feeding on infected animals. Bacteria move from tick saliva and feces into a host’s skin. Around 500,000 people in the U.S. become infected every year.
Lyme is the most common tick-borne illness in the country. Infection rates are rising, especially in the Northeast, Mid-Atlantic, and Midwest. The recent increase may be linked to relaxed disease tracking rules.
Early symptoms include fever, fatigue, and a bullseye-shaped rash. Quick antibiotic treatment can prevent serious heart, joint, or nerve damage. Persistent inflammation may cause arthritis and other long-term symptoms.
Lyme prevention is challenging, with no approved human vaccine currently available. However, a three-dose Lyme vaccine is now in Phase III trials. The trials include children and adults living in high-risk regions.
Conclusion
Piperacillin shows promising potential as a safer, targeted Lyme disease treatment. This antibiotic could reduce side effects and fully eliminate harmful bacteria. Continued research may lead to improved Lyme diagnosis, treatment, and patient outcomes.
Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.
Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.
US - English
CA - English
Rest of World - English
